Comparison study for the best use of the biologic agent in rheumatoid arthritis treatment with certolizumab pegol in the real world
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000016340
- Lead Sponsor
- ORTHERN CAPITAL CLINIC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who are inadequate for the treatment with certolizumab pegol according to the attached document of the drug must be excluded from participation in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method